Cell and gene therapies offer potentially transformative outcomes but can carry exceptionally high costs and complex coverage considerations. This article explains how a stronger understanding of these treatments can help self-funded plans make informed, sustainable coverage decisions.
PUBLISHER: The Self Insurer
© 2024 HHC Group. All Rights Reserved.
